ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CMRX Chimerix Inc

0.9529
0.00 (0.00%)
Pre Mercado
Última actualización: 03:48:36
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Chimerix Inc CMRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.9529 03:48:36
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.9529
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202406:00GLOBEChimerix Reports First Quarter 2024 Financial Results and..
24/4/202406:00GLOBEChimerix to Report First Quarter 2024 Financial Results and..
16/4/202415:05GLOBEChimerix Reports Inducement Grants Under Nasdaq Listing Rule..
21/3/202406:00GLOBEChimerix Appoints Marc D. Kozin to Board of Directors
29/2/202408:20EDGAR2Form S-3 - Registration statement under Securities Act of..
29/2/202407:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202406:58EDGAR2Form 8-K - Current report
29/2/202406:00GLOBEChimerix Reports Fourth Quarter and Year End 2023 Financial..
27/2/202406:00GLOBEChimerix to Present at TD Cowen 44th Annual Health Care..
22/2/202406:00GLOBEChimerix to Report Fourth Quarter and Year End 2023..
16/2/202419:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202412:28EDGAR2Form 144 - Report of proposed sale of securities
14/2/202412:21EDGAR2Form 144 - Report of proposed sale of securities
14/2/202412:13EDGAR2Form 144 - Report of proposed sale of securities
12/2/202405:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202410:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202410:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/12/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202315:51EDGAR2Form 8-K - Current report
29/12/202306:00GLOBEChimerix Appoints Lisa Decker to Board of Directors
04/12/202316:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202316:21EDGAR2Form 8-K - Current report
04/12/202306:00GLOBEChimerix Promotes Michelle LaSpaluto to Chief Financial..
24/11/202306:00GLOBEChimerix Reports Inducement Grant Under Nasdaq Listing Rule..
20/11/202314:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202317:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:15EDGAR2Form 8-K - Current report
16/11/202306:00GLOBEChimerix Strengthens Executive Leadership Team with..
13/11/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202307:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202307:02EDGAR2Form 8-K - Current report
02/11/202306:00GLOBEChimerix Reports Third Quarter 2023 Financial Results and..
26/10/202306:00GLOBEChimerix to Report Third Quarter 2023 Financial Results and..
29/9/202315:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/9/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202312:22EDGAR2Form 144 - Report of proposed sale of securities
26/9/202314:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202317:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202306:00GLOBEChimerix to Participate in Upcoming Investor Conferences
16/8/202309:05GLOBEChimerix Announces Data Highlighting Clinical Efficacy and..
03/8/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202306:11EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock